BEUDAMED
    FDA Adverse Event Injury Summary report: N

    MUGARD ORALL RINSE 24 ML/BTL

    MDR report key: 22440091 · Received July 8, 2025

    Report

    Report Number
    MW5172416
    Event Type
    Injury
    Date Received
    July 8, 2025
    Report Date
    July 2, 2025
    Manufacturer
    SOLEVA PHARMA LLC
    Product Code
    MGQ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    PHARMACIST
    Health Professional
    N

    Narratives

    Description of Event or Problem · 0

    PATIENTS BUSINESS PARTNER, (B)(6), REPORTED PATIENT IS IN THE HOSPITAL. FREQ: SWISH AND SWALLOW 5-10 MLS TWICE DAILY STARTING FIRST DAY OF RADIATION THERAPY. PRESCRIBER CONTACT INFORMATION: (B)(6).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    148689 MUGARD ORALL RINSE 24 ML/BTL DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC MGQ SOLEVA PHARMA LLC MV1040

    Patients

    Seq Age Sex Outcome Treatment
    1 NA Male Hospitalization EZETIMIBE TAB 10MG.| MONTELUKAST SODIUM.| OMEPRAZOLE CAP 40 MG.| PREDNISONE TAB 20MG.